Which class is your device — and what that decision costs.

One rule set, four risk tiers, one branch point that matters.

Malaysia classifies medical devices on the risk-based approach of the ASEAN Medical Device Directive. MDA publishes the harmonised class list as guidance document MDA/GD/0062, currently in its Third Edition, issued 13 June 2025. The document is refreshed roughly yearly to carry decisions of the ASEAN Medical Device Committee, and the current edition expanded its treatment of Software as a Medical Device.

Fees are published and all-inclusive — professional work, CAB fees and MDA statutory fees inside one number. Full schedule on pricing, with the three cost layers broken out in the cost guide.

The Class A / Class B line is the one worth understanding

Everything above Class A requires conformity assessment by a registered Conformity Assessment Body before MDA will consider the application. Class A does not — it goes straight to MeDC@St.

That single branch point explains most of what people find confusing about Malaysian device costs and timelines. The step from RM2,500 to RM6,000 is not a bigger margin on a riskier product; it is an entire review body entering the process. It is also why Class A approvals are consistently the fastest, and why an under-classified Class B submission does not get quietly corrected — it is missing a mandatory step, so the cycle restarts on the correct route.

What actually decides the class

Three factors, applied to the device as you intend it to be used:

• Intended purpose — what you claim the device does, as stated in your labelling and instructions for use. This is the dominant factor, and it is why marketing copy written loosely can raise your class.
• Invasiveness — whether the device enters the body, by what route, and how far.
• Duration of contact — transient, short-term or long-term contact with the patient.

What does not decide it: what the device is made of, what it costs, how it looks, or how a competitor's similar-looking product was registered. A competitor's class is a hint about their intended purpose, not a precedent for yours.

Grouping is where multi-device budgets are actually won.

MDA's grouping rules recognise four submission shapes — single, family, system and set. Where related devices meet the criteria, they share one dossier and one registration rather than being filed and paid for individually.

For a company bringing in a range rather than a single product, grouping strategy routinely saves more than any fee negotiation would. It is decided at classification, not afterwards, which is the practical reason classification is the first deliverable of every engagement we take.

Classification went fully online on 1 August 2026.

Product-classification applications are now submitted entirely through MeDC@St — the old form route is closed, and classification letters are issued by email only. An internal assumption about your class is not the same thing as a classification letter, and the difference shows up at exactly the wrong moment: after the dossier is built.

We lodge the classification application first, before any documentation work begins, so the fee, the evidence set and the timeline are known quantities before you commit to them.